Clinical Oncology
Volume 22, Issue 2 , Pages 114-118 , March 2010

Current Trends in the Follow-up of Head and Neck Cancer Patients in the UK

  • A. Joshi

      Affiliations

    • Department of Otorhinolaryngology Head and Neck Surgery, Guy's & St Thomas' NHS Trust, London, UK
    • ,
  • F. Calman

      Affiliations

    • Queen Elizabeth University Hospital, Birmingham, UK
    • ,
  • M. O'Connell

      Affiliations

    • Queen Elizabeth University Hospital, Birmingham, UK
    • ,
  • J.-P. Jeannon

      Affiliations

    • Department of Otorhinolaryngology Head and Neck Surgery, Guy's & St Thomas' NHS Trust, London, UK
    • ,
  • P. Pracy

      Affiliations

    • Department of Clinical Oncology, Guy's & St Thomas' NHS Trust, London, UK
    • ,
  • R. Simo

      Affiliations

    • Department of Otorhinolaryngology Head and Neck Surgery, Guy's & St Thomas' NHS Trust, London, UK
    • Corresponding Author InformationAuthor for correspondence: R. Simo, Department of Otorhinolaryngology Head and Neck Surgery, 3rd Floor Thomas Guy's House, Guy's Hospital, St Thomas Street, London SE1 9RT, UK. Tel: +44-207-188-7188; Fax: +44-207-188-2206.

Received 21 January 2008 ,Revised 12 October 2009 ,Accepted 5 November 2009.

References 

  1. Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2002;258:177–183
  2. Leemans CR, Tiwari R, Nauta JJP, et al. Recurrence at the primary site in head and neck cancer and the significance of neck lymph nodes metastases as a prognostic factor. Cancer. 1995;73:187–190
  3. Collins R, Flynn A, Melville A, et al. Effective health care: management of head and neck cancers. Qual Saf Health Care. 2005;14:144–148
  4. Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002;128(3):268–274
  5. Macfarlane GJ, Boyle P, Scully C. Oral cancer in Scotland: changing incidence and mortality. Br Med J. 1992;305(6862):1121–1123
  6. Wilson JA. Does pharma fund the pipers? - Scottish Intercollegiate Guidelines Network (SIGN) Guidelines 90-diagnosis and management of head and neck cancer. Clin Oncol. 2006;20(9):661–663
  7. Boysen M, Lovdal O, Tausjo J, et al. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992;23:426–430
  8. Schwartz D, Barker J, Chansky K, et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma – too much for too little. Head Neck. 2003;25:990–999
  9. Morton R, Hay KD, Macann A. On completion of curative treatment of head and neck cancer: why follow up?. Curr Opin Otolaryngol Head Neck Surg. 2004;12:142–146
  10. Sardell S, Sharpe G, Ashley S, et al. Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma. Clin Oncol. 2000;12:36–41
  11. Cox K, Wilson E. Follow-up for people with cancer: nurse-led services and telephone interventions. J Adv Nurs. 2003;43(1):51–61
  12. Virgo KS, Paniello RC, Johnson FE. Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg. 1998;124:564–572
  13. van Agthoven M, van Inevald BM, de Boer MF, et al. The costs of head and neck oncology: primary tumors, recurrent tumors and long term follow up. Eur J Cancer. 2001;37:2204–2211
  14. Di Martino E, Sellhaus B, Hausmann R, et al. Survival in second primary malignancies in head and neck cancer patients. J Laryngol Otol. 2002;116(10):831–838
  15. Department of Health . Referral guidelines for suspected cancer. 2000;www.dh.gov.uk
  16. Chong V, Fan Y-F. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology. 1997;202:463–470
  17. Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer. 2000;36:858–867
  18. O'Meara W, Thiringer J, Johnstone P. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol. 2003;66:323–326

PII: S0936-6555(09)00374-4

doi: 10.1016/j.clon.2009.11.004

Clinical Oncology
Volume 22, Issue 2 , Pages 114-118 , March 2010

Article Tools

* Image Usage & Resolution